Table 4.
The average positive cell number of CXCL12, CXCR4, MMP-2, MMP-9, and NGF expression in the three groups ( ± s)
Treatment | n | CXCL12 | CXCR4 | MMP-2 | MMP-9 | NGF |
AMD3100 | 10 | 11.64 ± 4.96 | 19.81 ± 0.91 | 13.94 ± 4.63 | 12.96 ± 3.20 | 24.25 ± 5.41 |
Untreated control | 10 | 18.30 ± 6.53 | 26.09 ± 5.48 | 22.47 ± 3.30 | 18.72 ± 3.26 | 31.72 ± 3.38 |
CXCL12 | 8 | 34.63 ± 5.04 | 53.83 ± 5.75 | 41.03 ± 8.21 | 32.97 ± 6.97 | 51.24 ± 13.87 |
F value | 18.77 | 78.05 | 40.54 | 32.66 | 22.54 |
The differences of positive cell number of CXCL12, CXCR4, MMP-2, MMP-9 and NGF expression of tumor cells among the three groups were all statistically significant(P < 0.05).